author-placeholder

Mr Chris Fotinopoulos

Chris is a Melbourne writer and ethicist. His work has been published by The New York Times, The Guardian, The Age, The Drum, Crikey, The Huffington Post and The Herald Sun.

More from this expert

Videos iconVideos

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Videos iconVideos

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Monographs iconMonographs

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Monographs iconMonographs

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Podcasts iconPodcasts

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Videos iconVideos

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Podcasts iconPodcasts

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Videos iconVideos

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Podcasts iconPodcasts

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Videos iconVideos

Upcoming Healthed Webcast

Oral Contraception Updates

Tuesday 28th October, 7pm - 9pm AEDT

Speaker

Prof Deborah Bateson

Professor of Practice, Faculty of Medicine and Health, The University of Sydney

We invite you to our next free webcast, where Prof Deborah Bateson will present on updates related to the oral contraceptive pill. Up to 4 hours CPD. RACGP & ACRRM accredited.